Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Edward F Knol

Showing results (61-70 of 69) with videos related to

Pageof 7
Sort By:
You have reached the last page of results.This site can display upto 69 results.
Clinical and Translational Allergy|May 17, 2017
Application of the adverse outcome pathway (AOP) concept to structure the available in vivo and in vitro mechanistic data for allergic sensitization to food proteinsJolanda H M van Bilsen, Edyta Sienkiewicz-Szłapka, Daniel Lozano-Ojalvo, et al.
The Lancet. Haematology|June 4, 2026
Diagnosis of primary CNS lymphoma through molecular and immune biomarkers in cerebrospinal fluid (PRICELUS): a multicentre, prospective, cohort studyJosephus L M van Rooij, Peter H Wessels, Johanna M Niers, et al.
Allergy|March 3, 2021
COVID-19 pandemic and allergen immunotherapy-an EAACI surveyOliver Pfaar, Ioana Agache, Matteo Bonini, et al.
Allergy|June 26, 2020
Immunology of COVID-19: Mechanisms, clinical outcome, diagnostics, and perspectives-A report of the European Academy of Allergy and Clinical Immunology (EAACI)Milena Sokolowska, Zuzanna M Lukasik, Ioana Agache, et al.
Clinical and Translational Allergy|November 29, 2024
10 practical priorities to prevent and manage serious allergic reactions: GA<sup>2</sup>LEN ANACare and EFA Anaphylaxis ManifestoAntonella Muraro, Debra de Silva, Marcia Podesta, et al.
Allergy|October 30, 2024
EAACI guidelines on the management of IgE-mediated food allergyAlexandra F Santos, Carmen Riggioni, Ioana Agache, et al.
Allergy|June 13, 2020
COVID-19 pandemic: Practical considerations on the organization of an allergy clinic-An EAACI/ARIA Position PaperOliver Pfaar, Ludger Klimek, Marek Jutel, et al.
Clinical and Translational Allergy|May 21, 2025
Towards a common approach for managing food allergy and serious allergic reactions (anaphylaxis) at school. GA<sup>2</sup>LEN and EFA consensus statementAntoine Deschildre, Montserrat Alvaro-Lozano, Antonella Muraro, et al.
Allergologie Select|September 11, 2020
Use of biologicals in allergic and type-2 inflammatory diseases during the current COVID-19 pandemic: Position paper of Ärzteverband Deutscher Allergologen (AeDA)<sup>A</sup>, Deutsche Gesellschaft für Allergologie und Klinische Immunologie (DGAKI)<sup>B</sup>, Gesellschaft für Pädiatrische Allergologie und Umweltmedizin (GPA)<sup>C</sup>, Österreichische Gesellschaft für Allergologie und Immunologie (ÖGAI)<sup>D</sup>, Luxemburgische Gesellschaft für Allergologie und Immunologie (LGAI)<sup>E</sup>, Österreichische Gesellschaft für Pneumologie (ÖGP)<sup>F</sup> in co-operation with the German, Austrian, and Swiss ARIA groups<sup>G</sup>, and the European Academy of Allergy and Clinical Immunology (EAACI)<sup>H</sup>Ludger Klimek, Oliver Pfaar, Margitta Worm, et al.
Pageof 7

Showing results (61-70 of 69) with videos related to

Sort By:
Pageof 7
You have reached the last page of results.This site can display upto 69 results.
Clinical and Translational Allergy|May 17, 2017
Application of the adverse outcome pathway (AOP) concept to structure the available in vivo and in vitro mechanistic data for allergic sensitization to food proteinsJolanda H M van Bilsen, Edyta Sienkiewicz-Szłapka, Daniel Lozano-Ojalvo, et al.
The Lancet. Haematology|June 4, 2026
Diagnosis of primary CNS lymphoma through molecular and immune biomarkers in cerebrospinal fluid (PRICELUS): a multicentre, prospective, cohort studyJosephus L M van Rooij, Peter H Wessels, Johanna M Niers, et al.
Allergy|March 3, 2021
COVID-19 pandemic and allergen immunotherapy-an EAACI surveyOliver Pfaar, Ioana Agache, Matteo Bonini, et al.
Allergy|June 26, 2020
Immunology of COVID-19: Mechanisms, clinical outcome, diagnostics, and perspectives-A report of the European Academy of Allergy and Clinical Immunology (EAACI)Milena Sokolowska, Zuzanna M Lukasik, Ioana Agache, et al.
Clinical and Translational Allergy|November 29, 2024
10 practical priorities to prevent and manage serious allergic reactions: GA<sup>2</sup>LEN ANACare and EFA Anaphylaxis ManifestoAntonella Muraro, Debra de Silva, Marcia Podesta, et al.
Allergy|October 30, 2024
EAACI guidelines on the management of IgE-mediated food allergyAlexandra F Santos, Carmen Riggioni, Ioana Agache, et al.
Allergy|June 13, 2020
COVID-19 pandemic: Practical considerations on the organization of an allergy clinic-An EAACI/ARIA Position PaperOliver Pfaar, Ludger Klimek, Marek Jutel, et al.
Clinical and Translational Allergy|May 21, 2025
Towards a common approach for managing food allergy and serious allergic reactions (anaphylaxis) at school. GA<sup>2</sup>LEN and EFA consensus statementAntoine Deschildre, Montserrat Alvaro-Lozano, Antonella Muraro, et al.
Allergologie Select|September 11, 2020
Use of biologicals in allergic and type-2 inflammatory diseases during the current COVID-19 pandemic: Position paper of Ärzteverband Deutscher Allergologen (AeDA)<sup>A</sup>, Deutsche Gesellschaft für Allergologie und Klinische Immunologie (DGAKI)<sup>B</sup>, Gesellschaft für Pädiatrische Allergologie und Umweltmedizin (GPA)<sup>C</sup>, Österreichische Gesellschaft für Allergologie und Immunologie (ÖGAI)<sup>D</sup>, Luxemburgische Gesellschaft für Allergologie und Immunologie (LGAI)<sup>E</sup>, Österreichische Gesellschaft für Pneumologie (ÖGP)<sup>F</sup> in co-operation with the German, Austrian, and Swiss ARIA groups<sup>G</sup>, and the European Academy of Allergy and Clinical Immunology (EAACI)<sup>H</sup>Ludger Klimek, Oliver Pfaar, Margitta Worm, et al.
Pageof 7